Skip to main content
. 2021 Aug 26;111:196–203. doi: 10.1016/j.ijid.2021.08.060

Table 1.

Clinical characteristics of adult IPD patients per time period. Data are presented as % (n) or mean (± standard deviation).

Dec-Feb period
Mar-May period
2014-2019 n=202 2019-2020 n=42 p-value 2015-2019 n=161 2020 n=13 p-value
1st wave COVID-19
Age (years) 68 ± 15 68 ± 14 0.97 67 ± 15 73 ± 14 0.20
Gender (female) 50.0 (101) 57.1 (24) 0.50 46.0 (74) 69.2 (9) 0.15
Nursing home residence 1.5 (3) 2.4 (1) 0.53 4.3 (7) 0 (0) 1
COPD 22.8 (46) 21.4 (9) 1 20.5 (33) 30.8 (4) 0.48
Diabetes mellitus type 2 21.3 (43) 14.3 (6) 0.40 16.8 (27) 15.4 (2) 1
Cancer 39.1 (79) 38.1 (16) 0.90 25.5 (41) 61.5 (8) 0.01
Body Mass Index 25.9 ± 5.4 29.2 ± 7.5 0.008 26.0 ± 4.8 24.9 ± 5.7 0.43
Confusion as symptom 16.8 (34) 16.7 (7) 1 20.5 (33) 7.7 (1) 0.47
Oxygen saturation (%) 93 ± 5 93 ± 5 0.27 93 ± 5 93 ± 6 0.73
Arterial blood pH 7.42 ± 0.10 7.44 ± 0.07 0.31 7.42 ± 0.08 7.40 ± 0.13 0.40
C-reactive protein (mg/dL) 245 ± 156 277 ± 166 0.23 249 ± 161 277 ± 169 0.55
Antibiotics use within 48h preceding admission 4.5 (9) 4.8 (2) 1 5.6 (9) 7.7 (1) 0.55
Pneumonia 84.7 (171) 83.3 (35) 0.82 82.0 (132) 76.9 (10) 0.71
Empyema 5.0 (10) 7.1 (3) 0.47 5.6 (9) 7.7 (1) 0.55
Meningitis 5.4 (11) 11.9 (5) 0.16 7.5 (12) 7.7 (1) 1
Unknown focus 5.4 (11) 4.8 (2) 1 6.3 (10) 7.7 (1) 0.59